Not finding it? Sign in to also search OpenAlex live.
-
The Extent and Nature of Functional Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Severe Functional Disability2024 Journal of Clinical Medicine article Medicine Rheumatoid Arthritis Research and Therapies Open access
M. Teuwen, MAT van Wissen, Wilfred F. Peter, Dirkjan van Schaardenburg, Cornelia H. M. van den Ende, Maaike G. J. Gademan, +1 more
8citations -
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept2022 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Joshua F. Baker, Philip G. Conaghan, Paul E. Emery, Tom W. J. Huizinga, Yedid Elbez, Subhashis Banerjee, +1 more
18citations -
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies2022 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Clifton O. Bingham, David Walker, Peter T. Nash, Sang Hyuck Lee, Lei Ye, Hao Hu, +2 more
10citations -
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Elise van Mulligen, Angelique E. A. M. Weel, J. M. W. Hazes, Annette H M van der Helm–van Mil, Pascal H P de Jong
50citations -
Physical function in older people with rheumatoid arthritis and population controls: a cross-sectional study of self-reported and performance-based measures2026 Rheumatology International article Medicine Rheumatoid Arthritis Research and Therapies Open access
Saskia P M Truijen, Annelies E. R. C. H. Boonen, Sofía Ramiro, Marloes van Onna
1citations -
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2)2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Roy Fleischmann, Désirée M F M van der Heijde, Vibeke Strand, Tatsuya Atsumi, Iain B. McInnes, Tsutomu Takeuchi, +13 more
39citations -
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis2025 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Agnes E M Looijen, Paco M J Welsing, Sytske Anne Bergstra, Annette H M van der Helm–van Mil, Pascal H P de Jong
3citations -
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis2022 Rheumatology and Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Bernard G Combe, Robin Besuyen, Antonio Gómez-Centeno, Tsukasa Matsubara, Juan José Sancho Jimenez, Zhaoyu Yin, +1 more
2citations -
Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status2021 The Open Rheumatology Journal article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul Emery, Ferdinand C. Breedveld, Eduardo Campos‐Alberto, Annette E. Szumski, Tomohiro Hirose
1citations -
Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning2023 Scandinavian Journal of Rheumatology article Decision Sciences Psychometric Methodologies and Testing Open access
MAT van Wissen, B. Straathof, T. P. M. Vliet Vlieland, Cornelia H. M. van den Ende, M. Teuwen, Wilfred F. Peter, +6 more
0citations -
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Placebo‐Controlled APEX Study
Christopher T. Ritchlin, Philip J. Mease, Laura C. Coates, Alexa P. Kollmeier, Bei Zhou, Yusang Jiang, +7 more
0citations -
The value of inquiring about functional impairments for early identification of inflammatory arthritis: a large cross-sectional derivation and validation study from the Netherlands
Bastiaan T van Dijk, Hanna W. van Steenbergen, Ellis Niemantsverdriet, Elisabeth Brouwer, Annette H M van der Helm–van Mil
9citations -
Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA
Sarah J H Khidir, Bastiaan T van Dijk, Doortje I Krijbolder, Marloes Verstappen, Elise van Mulligen, Annette H M van der Helm–van Mil
14citations -
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Philip J. Mease, Atul A. Deodhar, Désirée M F M van der Heijde, Frank Behrens, Alan Kivitz, Jeffrey Neal, +4 more
215citations -
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial2021 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
René Westhovens, William F. C. Rigby, Désirée M F M van der Heijde, D. W. T. CHING, William Stohl, Jonathan Kay, +13 more
150citations -
Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial2024 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
M. Teuwen, Salima F. E. van Weely, T. P. M. Vliet Vlieland, MAT van Wissen, Wilfred F. Peter, Alfons A den Broeder, +4 more
31citations -
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis2023 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access
Sophie I E Liem, Sytske Anne Bergstra, Jacopo Ciaffi, Coen van der Meulen, David A Ueckert, Rita Schriemer, +3 more
4citations -
SAT0104 MAINTENANCE OF SDAI REMISSION AND PATIENT-REPORTED OUTCOMES (PROS) FOLLOWING DOSE DE-ESCALATION OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+ PATIENTS WITH EARLY RA: RESULTS FROM AVERT-2, A RANDOMISED PHASE IIIB STUDY2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Tom W. J. Huizinga, Gustavo Citera, C.O. Bingham, +8 more
1citations